Koers Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE
Aandelen
TEVA
IL0006290147
Farmaceutische producten
Omzet 2024 * | 15,86 mld. 60,43 mld. 14,78 mld. | Omzet 2025 * | 16,35 mld. 62,27 mld. 15,23 mld. | Marktkapitalisatie | 15,01 mld. 57,17 mld. 13,98 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 1,54 mld. 5,86 mld. 1,43 mld. | Nettowinst (verlies) 2025 * | 1,44 mld. 5,49 mld. 1,34 mld. | EV/omzet 2024 * | 1,87 x |
Nettoschuld 2024 * | 14,62 mld. 55,71 mld. 13,63 mld. | Nettoschuld 2025 * | 12,12 mld. 46,17 mld. 11,29 mld. | EV/omzet 2025 * | 1,66 x |
K/w-verhouding 2024 * |
10,6
x | K/w-verhouding 2025 * |
9,91
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 89,71% |
Recentste transcriptie over Teva Pharmaceutical Industries Limited
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 01-01-23 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 22-12-19 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 01-09-15 |
Janet Vergis
BRD | Director/Board Member | 60 | 09-06-20 |
Sol Barer
CHM | Chairman | 76 | 01-01-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+24,17% | 556 mld. | |
-6,33% | 354 mld. | |
+19,90% | 331 mld. | |
+7,95% | 296 mld. | |
+13,45% | 233 mld. | |
+6,04% | 201 mld. | |
-10,51% | 193 mld. | |
-12,26% | 143 mld. | |
-6,47% | 144 mld. |